Global Bioresorbable Vascular Scaffold Market Size is valued at USD 179.7 Mn in 2024 and is predicted to reach USD 375.6 Mn by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034.
The market for bioresorbable scaffolds is growing due to an increase in acceptance of cardiovascular procedures due to the advantages provided, including full body absorption and an increase in lifestyle-related disorders like diabetes and obesity. The rise also influences the market for bioresorbable scaffolds in adopting unhealthy lifestyle habits like drinking alcohol, eating poorly, and not exercising, as well as advancements developed by major industry players to help arteries function normally again.
Additionally, the market for bioresorbable scaffolds is favourably impacted by changing lifestyles, population expansion, an increase in cardiovascular procedures, and rising healthcare costs. Research and development efforts to stop vascular recoil that permits anti-proliferative medication release to expand the lucrative potential for the bioresorbable.
Another element projected to contribute to the target market's growth during the projected period is the development of novel bioresorbable vascular scaffolds that aid patients with cardiovascular disorders. Furthermore, new product technologies, various products in development, and increased demand for biocompatible and safe coronary stents are other factors anticipated to fuel market expansion globally throughout the forecast period.
The bioresorbable vascular scaffold market is segmented based on product, diseases type, material type and end users. As per the product, the market is segmented as everolimus-eluting devices, novolimus-eluting devices, and sirolimus-eluting devices. The market is segmented as coronary and peripheral artery disease based on disease type. The market is segmented as Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate and Others based on material type. End users segment the market into hospitals, ambulatory surgical centres, cardiac catheterization labs and others.
The coronary artery disease category will hold a major share of the global bioresorbable vascular scaffold market in 2024. A bioresorbable vascular scaffold treats coronary and peripheral arterial obstruction related to coronary heart disease, ischemic heart disease, and other cardiovascular illnesses. The rising frequency of coronary heart disease, ischemic heart disease, and other cardiovascular disorders is predicted to raise demand for the bioresorbable vascular scaffold, ultimately fueling industrial expansion.
The hospital segment is likely to grow rapidly in the global bioresorbable vascular scaffold market. The primary source of money for the entire healthcare industry, which supports research and innovation, is the hospital sector, which is significant to the healthcare system. Thus, businesses are working hard to promote their goods and services at hospitals from a financial and marketing perspective. As a result of their enhanced patient care, hospitals have experienced profitable expansion.
As individuals get older, their immune systems decline, and they become more prone to illnesses and disorders, which increases the need for hospitals; there is an increasing need for frequent access to healthcare services. The region's well-developed healthcare infrastructure, which includes hospital beds, equipment, and increased government funding, is anticipated to hasten the growth of the hospitals.
The North American bioresorbable vascular scaffold market is expected to record the maximum market share in revenue shortly. This can be attributed to the sturdy focus on the environment in the region, with the growing adoption of Bioresorbable Vascular scaffolds in different industries, including food & beverages, personal care, packaging, automotive, and others. In addition, the region's chemical industry is focusing on producing Bioresorbable Vascular Scaffolds to develop sustainable and environmentally-friendly solutions.
The region's target market is expanding as a result of factors including rising demand for bio-based components across sectors and growing use of bioresorbable vascular scaffolds in the manufacturing of intermediate chemicals. In addition, Europe is anticipated to have tremendous growth. The elderly population in the area is growing swiftly, and obesity, coronary artery disease, peripheral artery disease, and heart disease are all on the rise.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 179.7 Mn |
| Revenue forecast in 2034 | USD 375.6 Mn |
| Growth rate CAGR | CAGR of 7.8% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Million, volume (number of units) and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | By Product Type, By Disease Type, By Material Type, By End-User. |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | BIOTRONIK Group of Companies, Meryl Life Sciences Pvt. Ltd., Kyoto Medical Planning Co., Ltd., Elixir Medical, Zorin Medical |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Bioresorbable Vascular Scaffold Market By Product Type
Bioresorbable Vascular Scaffold Market By Disease Type
Bioresorbable Vascular Scaffold Market By Material Type
Bioresorbable Vascular Scaffold Market By End-user
Bioresorbable Vascular Scaffold Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bioresorbable Vascular Scaffold Market Snapshot
Chapter 4. Global Bioresorbable Vascular Scaffold Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends Investment and Funding Analysis of Metaverse Industry
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. COVID-19 Impact on Industry
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Everolimus-eluting Device
5.2.2. Novolimus-eluting Device
5.2.3. Sirolimus-eluting Device
5.2.4. Others (Rapamycin, etc.)
Chapter 6. Market Segmentation 2: By Disease Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Type:
6.2.1. Coronary Artery Disease
6.2.2. Peripheral Artery Disease
Chapter 7. Market Segmentation 3: By Material Type Estimates & Trend Analysis
7.1. By Product Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Material Type:
7.2.1. Poly-L-Lactic Acid (PLLA)
7.2.2. Tyrosine-derived Polycarbonate
7.2.3. Others (Polydioxanone, etc.)
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product Type & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1.1. Hospital
8.2.1.2. Ambulatory Surgical Center
8.2.1.3. Cardiac Catheterization Lab
8.2.1.4. Others (research institutes, etc.)
Chapter 9. Bioresorbable Vascular Scaffold Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
9.1.2. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.1.3. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.1.4. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.2.2. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.2.3. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type 2021-2034
9.2.4. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User,2021-2034
9.2.5. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.3.2. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.3.3. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.3.4. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.3.5. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.4.2. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.4.3. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.4.4. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, (US$ Million)
9.5.2. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.5.3. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.5.4. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Kyoto Medical Planning Co., Ltd.
10.2.2. BIOTRONIK Group of Companies.
10.2.3. REVA Medical
10.2.4. Elixir Medical
10.2.5. Arterius
10.2.6. Meril Life Sciences Pvt. Ltd.
10.2.7. S3V Vascular Technologies
10.2.8. Zorion Medical
10.2.9. Medtronic (development phase)